Chemical SOP
Microbiology SOP
Warehouse SOP
Manufacturing SOP
Information technology SOP

PRINCIPLES/FREQUENCIES/ ACCEPTANCE CRITERIA/REFERENCES IN PHARMA

Every activity in Pharma have some frequencies whether it is revision of documents, qualification, validation, stability, Re-testing etc. While Acceptance criteria means numerical limits, ranges, or other criteria for tests that are used for or in making a decision to accept or reject a unit, lot, or batch of a PET drug product.

  1. Warehouse Frequencies
  2. Acceptance Criteria used in Warehouse
  3. Tablets (Principle/Frequencies/Acceptance Criteria/References)

1. Principles in Pharma (GMP / Quality Principles)

Key principles that govern all testing, monitoring and decisions:

  • Patient safety first – no compromise on product quality and purity.
  • GMP compliance – WHO GMP, Schedule M, EU-GMP, US FDA cGMP etc.
  • Risk-based approach – apply ICH Q9; more risk ⇒ more controls & checks.
  • Lifecycle / science-based decisions – align with ICH Q8–Q11 (development → validation → commercial).
  • ALCOA+ data integrity – Attributable, Legible, Contemporaneous, Original, Accurate + Complete, Consistent, Enduring, Available.
  • Continuous improvement – use deviations, OOS/OOT, complaints, audits and trends to improve processes.

2. Frequencies (How Often Things Are Done)

Typical examples (you can customise for your site/SOPs):

  • Environmental monitoring (EM)
    • Grade A/B: every batch / shift or continuous (viable & non-viable).
    • Grade C/D: daily to weekly based on risk.
  • Cleaning validation / verification
    • Initial 3 consecutive successful runs for validation.
    • Then routine cleaning verification every batch or at defined intervals until sufficient trend data.
  • Equipment qualification / calibration
    • Critical balances, thermometers, pressure gauges: usually 6–12 months.
    • HPLC/GC qualification: at defined intervals or performance-based.
  • Product testing
    • In-process controls (IPCs): as per stage (e.g. every 30 mins for compression).
    • Routine finished product testing: every batch.
    • Stability studies: as per ICH (0, 3, 6, 9, 12, 18, 24 months etc. for long-term/accelerated).

Make sure you mention that frequencies are justified via risk assessment & historical performance, not arbitrarily chosen.


3. Acceptance Criteria (Pass / Fail Limits)

These are the predefined limits that determine whether a result is acceptable:

  • Pharmacopoeial limits
    • Assay, related substances, dissolution, uniformity etc. as per IP/BP/Ph.Eur/USP monographs.
  • Environmental limits
    • Viable & non-viable particles in cleanrooms as per ISO 14644 / EU GMP Annex 1.
  • Microbial limits
    • Total viable count, absence of pathogens, sterility criteria as per pharmacopeia.
  • Process-specific limits
    • Blend uniformity %RSD, granule LOD, tablet hardness/friability etc. set during development/validation.
  • Cleaning limits
    • MACO (Maximum Allowable Carry Over) based on toxicological/therapeutic data and batch size.

4. References (Regulatory & Internal)

You can list typical reference sources used to define principles, frequencies and criteria:

External (Regulatory / Standards)

  • Schedule M / national GMP rules
  • WHO GMP, EU-GMP, US FDA 21 CFR Parts 210/211
  • ICH Guidelines
    • Q7 (API GMP)
    • Q8 (Pharmaceutical Development)
    • Q9 (Quality Risk Management)
    • Q10 (Pharmaceutical Quality System)
    • Q11 (Development & Manufacture of Drug Substances)
  • Pharmacopoeias – IP, BP, USP, Ph. Eur.
  • ISO 14644 for cleanrooms and associated controlled environments.

Internal

  • Site SOPs and validation protocols/reports
  • Risk assessment reports (FMEA, HACCP, 6M-based etc.)
  • Change control and deviation reports
  • Annual Product Quality Review (APQR/PQR)

AreaExample FrequencyAcceptance Criteria (Example)Key References
Environmental Monitoring (Grade A)Every batch / shift or continuousZero CFU; particle limits as per Annex 1EU-GMP Annex 1, ISO 14644, SOP…
Finished Product AssayEvery batch95.0–105.0% of label claimIP/USP monograph, SOP…
Cleaning VerificationEvery batch (initial); then risk-basedResidual API ≤ MACO; visually cleanCleaning validation protocol…
Balance CalibrationEvery 6–12 monthsWithin predefined toleranceMetrology SOP, manufacturer…

Leave a Reply

Your email address will not be published. Required fields are marked *

error: Content is protected !!